|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 879 |
FusionGeneSummary for ADH7_CXCR5 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: ADH7_CXCR5 | Fusion gene ID: 879 | Hgene | Tgene | Gene symbol | ADH7 | CXCR5 | Gene ID | 131 | 643 |
| Gene name | alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide | C-X-C motif chemokine receptor 5 | |
| Synonyms | ADH4 | BLR1|CD185|MDR15 | |
| Cytomap | 4q23 | 11q23.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | alcohol dehydrogenase class 4 mu/sigma chainalcohol dehydrogenase VIIalcohol dehydrogenase class IV mu/sigma chainalcohol dehydrogenase-7class IV sigma-1 alcohol dehydrogenaseclass IV sigmasigma alcohol dehydrogenasegastric alcohol dehydrogenaseret | C-X-C chemokine receptor type 5Burkitt lymphoma receptor 1, GTP binding protein (chemokine (C-X-C motif) receptor 5)Burkitt lymphoma receptor 1, GTP-binding proteinCXC-R5CXCR-5MDR-15chemokine (C-X-C motif) receptor 5monocyte-derived receptor 15 | |
| Modification date | 20180519 | 20180527 | |
| UniProtAcc | P40394 | P32302 | |
| Ensembl transtripts involved in fusion gene | ENST00000209665, ENST00000437033, ENST00000482593, ENST00000476959, | ENST00000292174, | |
| Fusion gene scores | * DoF score | 1 X 1 X 1=1 | 11 X 3 X 7=231 |
| # samples | 1 | 11 | |
| ** MAII score | log2(1/1*10)=3.32192809488736 | log2(11/231*10)=-1.0703893278914 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: ADH7 [Title/Abstract] AND CXCR5 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | ADH7 | GO:0001523 | retinoid metabolic process | 9600267 |
| Hgene | ADH7 | GO:0006069 | ethanol oxidation | 7876099|10969996 |
| Hgene | ADH7 | GO:0009617 | response to bacterium | 11410738 |
| Hgene | ADH7 | GO:0010430 | fatty acid omega-oxidation | 9600267 |
| Hgene | ADH7 | GO:0045471 | response to ethanol | 9600267 |
| Hgene | ADH7 | GO:0055114 | oxidation-reduction process | 7876099 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | HNSC | TCGA-CV-6940-01A | ADH7 | chr4 | 100333418 | - | CXCR5 | chr11 | 118754475 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000209665 | ENST00000292174 | ADH7 | chr4 | 100333418 | - | CXCR5 | chr11 | 118754475 | + |
| Frame-shift | ENST00000437033 | ENST00000292174 | ADH7 | chr4 | 100333418 | - | CXCR5 | chr11 | 118754475 | + |
| intron-3CDS | ENST00000482593 | ENST00000292174 | ADH7 | chr4 | 100333418 | - | CXCR5 | chr11 | 118754475 | + |
| intron-3CDS | ENST00000476959 | ENST00000292174 | ADH7 | chr4 | 100333418 | - | CXCR5 | chr11 | 118754475 | + |
Top |
FusionProtFeatures for ADH7_CXCR5 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ADH7 | CXCR5 |
| Could function in retinol oxidation for the synthesis ofretinoic acid, a hormone important for cellular differentiation.Medium-chain (octanol) and aromatic (m-nitrobenzaldehyde)compounds are the best substrates. Ethanol is not a good substratebut at the high ethanol concentrations reached in the digestivetract, it plays a role in the ethanol oxidation and contributes tothe first pass ethanol metabolism. | Cytokine receptor that binds to B-lymphocytechemoattractant (BLC). Involved in B-cell migration into B-cellfollicles of spleen and Peyer patches but not into those ofmesenteric or peripheral lymph nodes. May have a regulatoryfunction in Burkitt lymphoma (BL) lymphomagenesis and/or B-celldifferentiation. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ADH7_CXCR5 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ADH7_CXCR5 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| ADH7 | ADH7, CAND1, UBC, PI4KA | CXCR5 | CXCR4, GNB3, GNG8, GNAI2, GNA11, GNA13 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ADH7_CXCR5 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for ADH7_CXCR5 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | ADH7 | C0001973 | Alcoholic Intoxication, Chronic | 5 | PSYGENET |
| Hgene | ADH7 | C0014859 | Esophageal Neoplasms | 1 | CTD_human |
| Hgene | ADH7 | C0023055 | Laryngeal neoplasm | 1 | CTD_human |
| Hgene | ADH7 | C0026640 | Mouth Neoplasms | 1 | CTD_human |
| Hgene | ADH7 | C0031347 | Pharyngeal Neoplasms | 1 | CTD_human |
| Tgene | CXCR5 | C0023892 | Biliary cirrhosis | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|